NEOGENOMICS, INC. (NEO) Operating cash flow 2016–2025
NEOGENOMICS, INC. (NEO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$5.2MFY2025 · since FY2016: $21.5M → $5.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.2M | -25.5% |
| FY2024 | $7.0M | +459.6% |
| FY2023 | -$2.0M | +97.0% |
| FY2022 | -$66.0M | -147.0% |
| FY2021 | -$26.7M | -1930.3% |
| FY2020 | $1.5M | -93.8% |
| FY2019 | $23.4M | -47.8% |
| FY2018 | $44.8M | +148.3% |
| FY2017 | $18.0M | -16.0% |
| FY2016 | $21.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice